Viemed closes acquisition of Lehan's Medical Equipment for $26M base plus $2.2M earnout

VIEMED HEALTHCARE, INC.

Base purchase price $26M (subject to adjustments) plus estimated contingent consideration of ~$2.2M.
Lehan's 2024 net revenues ~$25.7M and Adjusted EBITDA ~$7.4M.
CEO cites Lehan's 80-year track record and preferred contracts to expand patient reach.
Viemed expects to update FY2025 guidance to reflect acquisition when reporting Q2 2025 earnings.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.